Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Major Quest restructure sees up to 600 managers head for the chop

This article was originally published in Clinica

Executive Summary

Quest Diagnostics is undergoing a major overhaul which will see three management layers pared off from the current business structure, resulting in the loss of 400 to 600 jobs by the end of 2013. The move, said the company, will enable it to "focus more on customers, speed up decision-making and accelerate cost reductions". While Quest will take a hit of about $15-20 million in charges from this management restructure, the company expects to gain about $65 million in annual savings.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT099509

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel